Literature DB >> 27161321

Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation.

Marion Dubuissez1, Ingrid Loison1, Sonia Paget1, Han Vorng2, Saliha Ait-Yahia2, Olivier Rohr3, Anne Tsicopoulos2, Dominique Leprince4.   

Abstract

The transcription factor BCL11B/CTIP2 is a major regulatory protein implicated in various aspects of development, function and survival of T cells. Mitogen-activated protein kinase (MAPK)-mediated phosphorylation and SUMOylation modulate BCL11B transcriptional activity, switching it from a repressor in naive murine thymocytes to a transcriptional activator in activated thymocytes. Here, we show that BCL11B interacts via its conserved N-terminal MSRRKQ motif with endogenous MTA1 and MTA3 proteins to recruit various NuRD complexes. Furthermore, we demonstrate that protein kinase C (PKC)-mediated phosphorylation of BCL11B Ser2 does not significantly impact BCL11B SUMOylation but negatively regulates NuRD recruitment by dampening the interaction with MTA1 or MTA3 (MTA1/3) and RbAp46 proteins. We detected increased phosphorylation of BCL11B Ser2 upon in vivo activation of transformed and primary human CD4(+) T cells. We show that following activation of CD4(+) T cells, BCL11B still binds to IL-2 and Id2 promoters but activates their transcription by recruiting P300 instead of MTA1. Prolonged stimulation results in the direct transcriptional repression of BCL11B by KLF4. Our results unveil Ser2 phosphorylation as a new BCL11B posttranslational modification linking PKC signaling pathway to T-cell receptor (TCR) activation and define a simple model for the functional switch of BCL11B from a transcriptional repressor to an activator during TCR activation of human CD4(+) T cells.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27161321      PMCID: PMC4911745          DOI: 10.1128/MCB.00062-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors.

Authors:  D Avram; A Fields; K Pretty On Top; D J Nevrivy; J E Ishmael; M Leid
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

2.  MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.

Authors:  Naoyuki Fujita; David L Jaye; Cissy Geigerman; Adil Akyildiz; Myesha R Mooney; Jeremy M Boss; Paul A Wade
Journal:  Cell       Date:  2004-10-01       Impact factor: 41.582

3.  Coordinated regulation of transcription factor Bcl11b activity in thymocytes by the mitogen-activated protein kinase (MAPK) pathways and protein sumoylation.

Authors:  Ling-juan Zhang; Walter K Vogel; Xiao Liu; Acharawan Topark-Ngarm; Brian L Arbogast; Claudia S Maier; Theresa M Filtz; Mark Leid
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

4.  NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.

Authors:  Dimitri Conomos; Roger R Reddel; Hilda A Pickett
Journal:  Nat Struct Mol Biol       Date:  2014-08-24       Impact factor: 15.369

5.  Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.

Authors:  Xin Huang; Si Chen; Qi Shen; Shaohua Chen; Lijian Yang; Piotr Grabarczyk; Grzegorz K Przybylski; Christian A Schmidt; Yangqiu Li
Journal:  Hematology       Date:  2011-07       Impact factor: 2.269

6.  The alpha4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A.

Authors:  Todd D Prickett; David L Brautigan
Journal:  J Biol Chem       Date:  2006-08-08       Impact factor: 5.157

7.  BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes.

Authors:  Valeriu B Cismasiu; Sailaja Ghanta; Javier Duque; Diana I Albu; Hong-Mei Chen; Rohini Kasturi; Dorina Avram
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

8.  The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Alex Kentsis; Takaomi Sanda; Linda Holmfeldt; Shann-Ching Chen; Jianhua Zhang; Alexei Protopopov; Lynda Chin; Suzanne E Dahlberg; Donna S Neuberg; Lewis B Silverman; Stuart S Winter; Stephen P Hunger; Stephen E Sallan; Shan Zha; Frederick W Alt; James R Downing; Charles G Mullighan; A Thomas Look
Journal:  Blood       Date:  2011-08-30       Impact factor: 22.113

9.  A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes.

Authors:  Sujit S Nair; Da-Qiang Li; Rakesh Kumar
Journal:  Mol Cell       Date:  2013-01-24       Impact factor: 17.970

10.  BCL11B is required for positive selection and survival of double-positive thymocytes.

Authors:  Diana I Albu; Dongyun Feng; Debarati Bhattacharya; Nancy A Jenkins; Neal G Copeland; Pentao Liu; Dorina Avram
Journal:  J Exp Med       Date:  2007-11-06       Impact factor: 14.307

View more
  15 in total

1.  The N-Terminal CCHC Zinc Finger Motif Mediates Homodimerization of Transcription Factor BCL11B.

Authors:  Passorn Winkler; Martin Delin; Piotr Grabarczyk; Praveen K Sappa; Sander Bekeschus; Petra Hildebrandt; Grzegorz K Przybylski; Uwe Völker; Elke Hammer; Christian A Schmidt
Journal:  Mol Cell Biol       Date:  2018-02-12       Impact factor: 4.272

2.  Ush regulates hemocyte-specific gene expression, fatty acid metabolism and cell cycle progression and cooperates with dNuRD to orchestrate hematopoiesis.

Authors:  Jonathan Lenz; Robert Liefke; Julianne Funk; Samuel Shoup; Andrea Nist; Thorsten Stiewe; Robert Schulz; Yumiko Tokusumi; Lea Albert; Hartmann Raifer; Klaus Förstemann; Olalla Vázquez; Tsuyoshi Tokusumi; Nancy Fossett; Alexander Brehm
Journal:  PLoS Genet       Date:  2021-02-18       Impact factor: 5.917

3.  A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.

Authors:  Jacqueline A C Goos; Walter K Vogel; Hana Mlcochova; Christopher J Millard; Elahe Esfandiari; Wisam H Selman; Eduardo Calpena; Nils Koelling; Evan L Carpenter; Sigrid M A Swagemakers; Peter J van der Spek; Theresa M Filtz; John W R Schwabe; Urszula T Iwaniec; Irene M J Mathijssen; Mark Leid; Stephen R F Twigg
Journal:  Hum Mol Genet       Date:  2019-08-01       Impact factor: 6.150

4.  14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.

Authors:  Danika Di Giacomo; Roberta La Starza; Paolo Gorello; Fabrizia Pellanera; Zeynep Kalender Atak; Kim De Keersmaecker; Valentina Pierini; Christine J Harrison; Silvia Arniani; Martina Moretti; Nicoletta Testoni; Giovanna De Santis; Giovanni Roti; Caterina Matteucci; Renato Bassan; Peter Vandenberghe; Stein Aerts; Jan Cools; Beat Bornhauser; Jean-Pierre Bourquin; Rocco Piazza; Cristina Mecucci
Journal:  Blood       Date:  2021-09-02       Impact factor: 22.113

5.  HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1.

Authors:  Valentin Le Douce; Faezeh Forouzanfar; Sebastian Eilebrecht; Benoit Van Driessche; Amina Ait-Ammar; Roxane Verdikt; Yoshihito Kurashige; Céline Marban; Virginie Gautier; Ermanno Candolfi; Arndt G Benecke; Carine Van Lint; Olivier Rohr; Christian Schwartz
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

6.  Gga-miR-219b targeting BCL11B suppresses proliferation, migration and invasion of Marek's disease tumor cell MSB1.

Authors:  Chunfang Zhao; Xin Li; Bo Han; Zhen You; Lujiang Qu; Changjun Liu; Jiuzhou Song; Ling Lian; Ning Yang
Journal:  Sci Rep       Date:  2017-06-26       Impact factor: 4.379

7.  HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).

Authors:  Sonia Paget; Marion Dubuissez; Vanessa Dehennaut; Joe Nassour; Brennan T Harmon; Nathalie Spruyt; Ingrid Loison; Corinne Abbadie; Brian R Rood; Dominique Leprince
Journal:  Oncotarget       Date:  2017-01-10

8.  HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.

Authors:  F Forouzanfar; S Ali; C Wallet; M De Rovere; C Ducloy; H El Mekdad; M El Maassarani; A Aït-Ammar; J Van Assche; E Boutant; F Daouad; F Margottin-Goguet; C Moog; C Van Lint; C Schwartz; O Rohr
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

Review 9.  Bcl11 Transcription Factors Regulate Cortical Development and Function.

Authors:  Ruth Simon; Christoph Wiegreffe; Stefan Britsch
Journal:  Front Mol Neurosci       Date:  2020-04-08       Impact factor: 5.639

Review 10.  Bcl11b/Ctip2 in Skin, Tooth, and Craniofacial System.

Authors:  Marie-Thérèse Daher; Pedro Bausero; Onnik Agbulut; Zhenlin Li; Ara Parlakian
Journal:  Front Cell Dev Biol       Date:  2020-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.